Cargando…

New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies

Hereditary neuropathies are of variable genotype and phenotype. With upcoming therapies, there is urgent need for early disease recognition and outcome measures. High-resolution nerve and muscle ultrasound is a dynamic, non-invasive, well-established tool in the field of inflammatory and traumatic n...

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Natalie, Vittore, Debora, Gess, Burkhard, Schulz, Jörg B., Grimm, Alexander, Dohrn, Maike F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804010/
https://www.ncbi.nlm.nih.gov/pubmed/34708324
http://dx.doi.org/10.1007/s13311-021-01141-3
_version_ 1784642993556291584
author Winter, Natalie
Vittore, Debora
Gess, Burkhard
Schulz, Jörg B.
Grimm, Alexander
Dohrn, Maike F.
author_facet Winter, Natalie
Vittore, Debora
Gess, Burkhard
Schulz, Jörg B.
Grimm, Alexander
Dohrn, Maike F.
author_sort Winter, Natalie
collection PubMed
description Hereditary neuropathies are of variable genotype and phenotype. With upcoming therapies, there is urgent need for early disease recognition and outcome measures. High-resolution nerve and muscle ultrasound is a dynamic, non-invasive, well-established tool in the field of inflammatory and traumatic neuropathies. In this study, we defined nerve and muscle ultrasound parameters as recognition and progression markers in 150 patients with genetically confirmed hereditary neuropathies, including Charcot-Marie-Tooth (CMT) disease (CMT1A, n = 55; other CMT1/4, n = 28; axonal CMT, n = 15; CMTX, n = 15), hereditary neuropathy with liability to pressure palsies (HNPP, n = 16), hereditary transthyretin-amyloidosis (ATTRv, n = 14), and Fabry’s disease (n = 7). The CMT1A, followed by the CMT1/4 group, had the most homogeneous enlargement of the nerve cross-sectional areas (CSA) in the ultrasound pattern sum (UPSS) and homogeneity score. Entrapment scores were highest in HNPP, ATTRv amyloidosis, and Fabry’s disease patients. In demyelinating neuropathies, the CSA correlated inversely with nerve conduction studies. The muscle echo intensity was significantly highest in the clinically most affected muscles, which was independent from the underlying disease cause and correlated with muscle strength and disease duration. Further correlations were seen with combined clinical (CMTES-2) and electrophysiological (CMTNS-2) scores of disease severity. We conclude that nerve ultrasound is a helpful tool to distinguish different types of hereditary neuropathies by pattern recognition, whereas muscle ultrasound is an objective parameter for disease severity. The implementation of neuromuscular ultrasound might enrich diagnostic procedures both in clinical routines and research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13311-021-01141-3.
format Online
Article
Text
id pubmed-8804010
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88040102022-02-02 New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies Winter, Natalie Vittore, Debora Gess, Burkhard Schulz, Jörg B. Grimm, Alexander Dohrn, Maike F. Neurotherapeutics Original Article Hereditary neuropathies are of variable genotype and phenotype. With upcoming therapies, there is urgent need for early disease recognition and outcome measures. High-resolution nerve and muscle ultrasound is a dynamic, non-invasive, well-established tool in the field of inflammatory and traumatic neuropathies. In this study, we defined nerve and muscle ultrasound parameters as recognition and progression markers in 150 patients with genetically confirmed hereditary neuropathies, including Charcot-Marie-Tooth (CMT) disease (CMT1A, n = 55; other CMT1/4, n = 28; axonal CMT, n = 15; CMTX, n = 15), hereditary neuropathy with liability to pressure palsies (HNPP, n = 16), hereditary transthyretin-amyloidosis (ATTRv, n = 14), and Fabry’s disease (n = 7). The CMT1A, followed by the CMT1/4 group, had the most homogeneous enlargement of the nerve cross-sectional areas (CSA) in the ultrasound pattern sum (UPSS) and homogeneity score. Entrapment scores were highest in HNPP, ATTRv amyloidosis, and Fabry’s disease patients. In demyelinating neuropathies, the CSA correlated inversely with nerve conduction studies. The muscle echo intensity was significantly highest in the clinically most affected muscles, which was independent from the underlying disease cause and correlated with muscle strength and disease duration. Further correlations were seen with combined clinical (CMTES-2) and electrophysiological (CMTNS-2) scores of disease severity. We conclude that nerve ultrasound is a helpful tool to distinguish different types of hereditary neuropathies by pattern recognition, whereas muscle ultrasound is an objective parameter for disease severity. The implementation of neuromuscular ultrasound might enrich diagnostic procedures both in clinical routines and research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13311-021-01141-3. Springer International Publishing 2021-10-27 2021-10 /pmc/articles/PMC8804010/ /pubmed/34708324 http://dx.doi.org/10.1007/s13311-021-01141-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Winter, Natalie
Vittore, Debora
Gess, Burkhard
Schulz, Jörg B.
Grimm, Alexander
Dohrn, Maike F.
New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies
title New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies
title_full New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies
title_fullStr New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies
title_full_unstemmed New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies
title_short New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies
title_sort new keys to early diagnosis: muscle echogenicity, nerve ultrasound patterns, electrodiagnostic, and clinical parameters in 150 patients with hereditary polyneuropathies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804010/
https://www.ncbi.nlm.nih.gov/pubmed/34708324
http://dx.doi.org/10.1007/s13311-021-01141-3
work_keys_str_mv AT winternatalie newkeystoearlydiagnosismuscleechogenicitynerveultrasoundpatternselectrodiagnosticandclinicalparametersin150patientswithhereditarypolyneuropathies
AT vittoredebora newkeystoearlydiagnosismuscleechogenicitynerveultrasoundpatternselectrodiagnosticandclinicalparametersin150patientswithhereditarypolyneuropathies
AT gessburkhard newkeystoearlydiagnosismuscleechogenicitynerveultrasoundpatternselectrodiagnosticandclinicalparametersin150patientswithhereditarypolyneuropathies
AT schulzjorgb newkeystoearlydiagnosismuscleechogenicitynerveultrasoundpatternselectrodiagnosticandclinicalparametersin150patientswithhereditarypolyneuropathies
AT grimmalexander newkeystoearlydiagnosismuscleechogenicitynerveultrasoundpatternselectrodiagnosticandclinicalparametersin150patientswithhereditarypolyneuropathies
AT dohrnmaikef newkeystoearlydiagnosismuscleechogenicitynerveultrasoundpatternselectrodiagnosticandclinicalparametersin150patientswithhereditarypolyneuropathies